Author Contributions Conceived and designed the experiments: XC YC. Performed the experiments: LG JZ. Analyzed the data: ZZ AJMV WJMVdV. References 1. Mejias R, Perez-Yague S, Gutierrez L, Cabrera LI, Spada R, et al. (2011) Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy. Biomaterials 32(11): 2938–2952. 2. Sanson C, Diou O, Thevenot J, Ibarboure E, Soum A, et al. (2011) Doxorubicin Loaded Magnetic Polymersomes: Theranostic Nanocarriers for MR Imaging and Magneto-Chemotherapy. ACS Nano 5(2): 1122–40. 3. Jain KK (2010) Advances in the field of nanooncology. BMC Med 8: 83. 4. Singh A, Dilnawaz F, Mewar S, Sharma U, Jagannathan NR, et al. (2011) Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. ACS Appl Mater Interfaces 3(3): 842–856. 5. Yang XQ, Hong H, Grailer JJ, Rowland IJ, Javadi A, et al. (2011) cRGD- functionalized, DOX-conjugated, and (64)Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32: 4151–4160. 6. Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, et al. (2008) In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 26(1): 83–90. 7. Gibson JD, Khanal BP, Zubarev ER (2007) Paclitaxel-Functionalized Gold Nanoparticles. J Am Chem Soc 129: 11653–11661. 8. Zharov VP, Letfullin RR, Galitovskaya EN (2005) Microbubbles-overlapping mode for laser killing of cancer cells with absorbing nanoparticle clusters. J Phys DAppl Phys 38: 2571–2581. 9. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26: 3995–4021. 10. Lin J, Zhou WL, Kumbhar A, Wiemann J, Fang JY, et al. (2001) Gold-coated iron (Fe@Au) nanoparticles: synthesis, characterization, and magnetic field- induced selfassembly. J Solid State Chem 159: 26–31. 11. Kim J, Park S, Lee JE, Jin SM, Lee JH, et al. (2006) Designed Fabrication of Multifunctional Magnetic Gold Nanoshells and Their Application to Magnetic Resonance Imaging and Photothermal Therapy. Angew Chem Int Ed 45: 7754– 7758. 12. Chao X, Guo LL, ZhaoYY, Hua K, Peng ML, et al. (2011) PEG-modified GoldMag nanoparticles (PGMNs) combined with the magnetic field for local drug delivery. J Drug Target 19(3): 161–170. 13. Chao X, Shi F, Zhao YY, Li K, Peng ML, et al. (2010) Cytotoxicity of Fe3O4/ Au composite nanoparticles loaded with doxorubicin combined with magnetic field. Pharmazie 65(7): 500–504. 14. Li Z, Jian L, Wang H, Cui Y (2007) Flow injection chemiluminescent determination of clenbuterol using GoldMag particles as carrier. Food Addit Contam 24(1): 21–25. 15. Zhao X, Cai Y, Wang T, Shi Y, Jiang G (2008) Preparation of alkanethiolate- functionalized core/shell Fe3O4@Au nanoparticles and its interaction with several typical target molecules. Anal Chem 80(23): 9091–9096. 16. Cui YL, Wang Y, Hui WL, Zhang Z, Xin X, et al. (2005) The synthesis of GoldMag nano-particles and their application for antibody immobilization. Biomed Microdevices 7(2): 153–156. Drug Nanoparticle Carrier for Cancer Chemotherapy Contributed reagents/materials/analysis tools: MP. Wrote the paper: XC ZZ AJMV WJMVdV CC YC. 17. Shubayev VI, Pisanic TR II, Jin S (2009) Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61(6): 467–477. 18. Zamboni WC (2008) Concept and clinical evaluation of carrier-mediated anticancer agents. Oncologist 13(3): 248–260. 19. Kuruppuachchi M, Savoie H, Lowry A, Boyle RW (2011) Polyacrylamide Nanoparticles as a Delivery System in Photodynamic Therapy. Mol Pharm 8: 920–931. 20. Meng Y, Zou C, Madiyalakan R, Woo T, Huang M, et al. (2010) Water-soluble and biocompatible sono/photosensitizer nanoparticles for enhanced cancer therapy. Nanomedicine 5(10): 1559–1569. 21. Huynh NT, Roger E, Lautram N, Benoit JP, Passirani C (2010) The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. Nanomedicine 5(9): 1415–1433. 22. Shukla S, Wu G, Chatterjee M, Yang W, Sekido M, et al. (2003) Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjug Chem 14(1): 158– 167. 23. Kim D, Park S, Lee JH, Jeong YY, Jon S (2007) Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 129: 7661–7665. 24. Carr BI (2004) Hepatocellular carcinoma: current management and future trends. Gastroenterology 127: 218–224. 25. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, et al. (2004) Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11(3): 169–183. 26. Gupta AK, Gupta M (2005) Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26(13): 1565–1573. 27. Huang X, Li B, Zhang H, Hussain I, Liang L, et al. (2011) Facile preparation of size-controlled gold nanoparticles using versatile and end-functionalized thioether polymer ligands. Nanoscale 3 (4): 1600–1607. 28. Lee W, Cho NJ, Xiong A, Glenn JS, Frank CW (2010) Hydrophobic nanoparticles improve permeability of cell-encapsulating poly(ethylene glycol) hydrogels while maintaining patternability. Proc Natl Acad Sci 107(48): 20709– 20714. 29. Cho WS, Cho M, Jeong J, Choi M, Han BS, et al. (2010) Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245(1): 116– 123. 30. Cho WS, Cho M, Jeong J, Choi M, Han BS, et al. (2009) Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236(1): 16–24. 31. Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma in the era of molecular targeted therapies. Hepatology 52(2): 762–773. 32. Bajaj G, Yeo Y(2010) Drug delivery systems for intraperitoneal therapy. Pharm Res 27(5): 735–738. PLOS ONE | www.plosone.org 7 October 2012 | Volume 7 | Issue 10 | e40388